"Il campus di Roma dell’Università Cattolica del Sacro Cuore, con la Facoltà di Medicina e Chirurgia e la Facoltà di Economia, garantisce un’offerta formativa all’avanguardia, interdisciplinare e sempre più apprezzata da studenti internazionali. Grazie alla prestigiosa partnership con la Fondazione Policlinico Universitario Agostino Gemelli IRCCS, la sinergia tra didattica, ricerca e assistenza sanitaria costituisce un “laboratorio formativo” unico dove gli studenti possono “sperimentare” le conoscenze acquisite in aula confrontandosi con l’attività clinica e la complessità organizzativa e gestionale. Soluzioni architettoniche moderne offrono un ambiente funzionale e accogliente che favorisce la collaborazione e lo scambio culturale."

During the past decade, Universita Cattolica Del Sacro Cuore conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 18 clinical trials were completed, i.e. on average, 48.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 11 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universita Cattolica Del Sacro Cuore" #1 sponsor was "Catholic University of the Sacred Heart" with 9 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials sponsored, "Laboratoire français de Fractionnement et de Biotechnologies" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita Cattolica Del Sacro Cuore" #1 collaborator was "Catholic University of the Sacred Heart" with 4 trials as a collaborator, "Myeloproliferative Disorders-Research Consortium" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Newcastle-upon-Tyne Hospitals NHS Trust" with 3 trials as a collaborator and "Institut Necker Enfants Malades" with 2 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Universita Cattolica Del Sacro Cuore" are "Coronary Artery Disease" (4 trials), "Ovarian Cancer" (3 trials), "Alzheimer's Disease" (2 trials), "Aortic Stenosis" (2 trials) and "Aortic Valve Disease" (2 trials). Many other conditions were trialed in "Universita Cattolica Del Sacro Cuore" in a lesser frequency.

Most popular intervention types in "Universita Cattolica Del Sacro Cuore" are "Drug" (40 trials), "Device" (9 trials), "Procedure" (9 trials), "Other" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aspirin" (2 trials), "Carboplatin" (2 trials), "Extended-release Guanfacine Hydrochloride" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universita Cattolica Del Sacro Cuore" are 71 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Universita Cattolica Del Sacro Cuore". 1 are not yet recruiting, 12 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Universita Cattolica Del Sacro Cuore, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Universita Cattolica Del Sacro Cuore, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".